Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCAP-XX Regulatory News (CPX)

Share Price Information for CAP-XX (CPX)

Share Price is delayed by 15 minutes
Get Live Data
0.25    0.00 (0.00%)
Bid:
0.24
Ask:
0.26
Spread: 0.02 (8.333%)
Market Cap: £14.49m
CPX Live PriceLast checked at - London Stock Exchange

Intraday CAP-XX Share Chart

Placing and Trading Update

24 May 2011 07:00

RNS Number : 1346H
CAP-XX Limited
24 May 2011
 



 

24 May 2011

 

CAP-XX Limited

(the "Company" or "CAP-XX")

 

Placing and Trading Update

 

CAP-XX Limited (AIM:CAPX.L), announces that Seymour Pierce Ltd has on behalf of the Company, placed 9,072,813 new ordinary shares of NPV ("New Ordinary Shares") at a price of 16 pence, to raise approximately £1.5 million before expenses (the "Placing"). CAP-XX is a world leader in the design and manufacture of revolutionary thin-form supercapacitors which considerably extend the performance of batteries in small portable devices.

 

The proceeds of the placing are to be used for the development of supercapacitor products and working capital purposes.

 

Placing details

 

Seymour Pierce Ltd has placed 9,072,813 New Ordinary Shares on behalf of the Company with institutional investors. The Placing is conditional, inter alia, upon Admission and will raise £1,451,650 before expenses.

 

Application will be made for the New Ordinary Shares issued pursuant to the Placing to be admitted to trading on AIM and it is anticipated that Admission will become effective and that dealings will commence on 1 June 2011.

 

The Placing Shares will, when issued, rank equally in all respects with the existing ordinary shares and will represent approximately 11.8 per cent of the entire issued share capital of the Company immediately following Admission.

 

Following the Placing the Company will have 77,032,097 ordinary shares in issue. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in CAP-XX Limited, under the Disclosure and Transparency Rules.

 

 

 

For further information, please contact

 

CAP-XX Limited

Anthony Kongats, Chief Executive Officer

 

+61 (0) 2 9428 0139

Seymour Pierce Ltd

Nandita Sahgal/Catherine Leftley (Nominated Adviser)

David Banks (Corporate Broking)

 

+44 (0) 20 7107 8000

 

Kreab Gavin Anderson & Company (Financial PR)

Robert Speed, Deborah Walter, Anthony Hughes

 

+44 (0) 20 7074 1800

 

Notes to Editors:

 

CAP-XX is a world leader in the design and manufacture of thin form supercapacitors and energy management systems, predominantly for portable electronic devices.

 

The unique feature of CAP-XX's supercapacitors is their ability to store high volumes of energy and output high power levels within a thin form design. These attributes will be critical for the next generation of high volume, power-hungry portable electronic devices, including mobile phones.

 

Portable devices are one of the fastest growing segments of the electronics market and provide the greatest opportunities for CAP-XX's products. CAP-XX's products are already an established enabling technology for the current generation of wireless devices and portable devices. 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEAJMRTMBBTBMB
Date   Source Headline
2nd Jul 20197:00 amRNSUS court action settlement and licence agreement
25th Jun 201910:45 amRNSIssue of Shares and Director/PDMR Shareholdings
7th Jun 20198:59 amRNSHolding(s) in Company
6th Jun 20199:03 amRNSTrading Update
30th May 20198:27 amRNSHolding(s) in Company
17th Apr 20193:09 pmRNSHolding(s) in Company
16th Apr 20197:00 amRNSTrading Update
6th Mar 20197:00 amRNSInterim Results
1st Mar 20197:36 amRNSDirector Disclosure Update
22nd Jan 20198:32 amRNSHolding(s) in Company
20th Dec 20188:43 amRNSIssue of Shares and Director/PDMR Shareholdings
20th Nov 20188:29 amRNSResult of AGM and Chairman's AGM statement
14th Nov 20187:00 amRNSHolding(s) in Company
5th Nov 20187:00 amRNSSubscription to raise £1.75 million
23rd Oct 20187:00 amRNSExercise of share options & PDMR shareholding
22nd Oct 201810:09 amRNSNotice of AGM
17th Oct 20187:00 amRNSAudited results for the year ended 30 June 2018
8th Oct 20182:05 pmRNSSecond Price Monitoring Extn
8th Oct 20182:00 pmRNSPrice Monitoring Extension
8th Oct 20187:00 amRNSNew licence agreement with TDK
5th Oct 20188:00 amRNSNotice of Results
25th Sep 201810:22 amRNSSpire Health Tags launched in Apple stores
18th Jul 20188:30 amRNSDirector/PDMR Shareholding
13th Jul 20187:00 amRNSExercise of share options
22nd Jun 20187:00 amRNSIssue of Shares and Director/PDMR Shareholdings
21st Jun 20187:00 amRNSExercise of share options & PDMR shareholding
20th Jun 20187:00 amRNSTrading update
1st May 20187:00 amRNSExercise of employee share options
11th Apr 20187:00 amRNSDeveloping first 3V thin prismatic supercapacitors
6th Mar 20182:25 pmRNSInterim Results (Replacement)
6th Mar 20187:00 amRNSInterim Results
15th Feb 20188:46 amRNSNotice of results
16th Jan 20187:00 amRNSHolding(s) in Company
18th Dec 201711:42 amRNSGrant of Share Options
12th Dec 201710:35 amRNSIssue of Shares and Director/PDMR Shareholdings
23rd Nov 20179:40 amRNSResult of AGM and Chairman's AGM statement
20th Nov 20177:00 amRNSSpire launches Thinline enabled wearable
30th Oct 20177:00 amRNSNotice of AGM
9th Oct 20177:00 amRNSAudited results for the year ended 30 June 2017
22nd Sep 20178:59 amRNSHolding(s) in Company
22nd Sep 20177:00 amRNSNotice of Results
23rd Aug 20178:37 amRNSHolding(s) in Company
15th Aug 20177:00 amRNSFirst high-volume order for Thinline
29th Jun 20178:22 amRNSIssue of Shares and Director/PDMR Shareholdings
7th Jun 20177:00 amRNSTrading update for year ending 30 June 2017
25th May 20178:51 amRNSExtension of option term and Director/PDMR dealing
19th Apr 20178:47 amRNSHolding(s) in Company
20th Mar 20177:00 amRNSInterim Results
9th Mar 20177:00 amRNSCAP-XX launches new cylindrical supercapacitors
1st Feb 20177:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.